Bioanalysis

Algorithme Pharma has more than one hundred dedicated Bioanalytical scientists working with the latest equipment to ensure compliant and on-time regulatory submissions. We provide Bioanalytical support for all stages of drug development from preclinical studies (non-GLP and GLP) through all phases of clinical development (Phase I-IV) for both small and large molecules.

LC-MS/MS & Ligand Binding Bioanalytical Platforms

Algorithme Pharma provides Bioanalytical support for all stages of drug development from preclinical studies (non-GLP and GLP) through all phases of clinical development (Phase I-IV) for both small and large molecule programs; including Immunogenicity, Biomarker and Anti-Drug Antibody testing.  With the combination of highly sensitive platforms and multiple sophisticated techniques, our extensive expertise with both generic compounds and New Molecular Entities (NME) in all biological matrices ensure highly sensitive and reliable methods.

Immunogenicity Services

We provide immunogenicity services by developing and applying methods commonly required in safety and efficacy studies, such as PK/PD, bridging immunogenicity, drug tolerance and neutralization assays.

Ligand Binding

Our team provide a broad spectrum of Ligand Binding Services which are customized to specific sponsor needs. Our experienced and dedicated scientists develop and validate tailored assays to support preclinical and clinical drug development.

Method Development Strategy

The method development team consists of dedicated scientists with over 150 years of combined experience in the bioanalytical and method development fields.

Preclinical

For your preclinical studies, you need a partner that provides strong bioanalytical support.

Dried Blood Spot Analysis (DBS)

We have added Dried Blood Spot (DBS) Analysis to our bioanalysis services.

Clinical Sample Kits & Management Support

Preparing, collecting and shipping clinical samples from trial sites to bioanalysis laboratories is a critical support service when managing clinical programs.